Cadus Corporation - KDUS- Profile

Cadus Corporation Formerly known as Cadus Pharmaceutical Corporation. The Group's principal activity is to seek to license its technologies and realize value from its assets. It also seeks to use a portion of its available cash to acquire technologies or products or to acquire or invest in companies. In December 2001, the Group organized a wholly owned subsidiary, Cadus Technologies, Inc and transferred its yeast-based drug discovery technologies to the Subsidiary. On 19-Dec-2001, the subsidiary licensed its yeast-based drug discovery technologies including various reagents and its library of over 25,000 yeast strains, on a non-exclusive basis to OSI Pharmaceuticals, Inc. Seeks to license its yeast based drug discovery technologies and realize value from its assets